Parkman Healthcare Partners LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001777015

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q1 2026 · 90 positions · Total reported value $969.64M · Top-10 concentration 34.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 68.0% · 26 new · 31 cut · 13 exited

Active Share (vs S&P 500): 97.4% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.8% · vs SPY -4.9% · Prev Value $976.83M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.8% · vs SPY -4.0% · Latest Value $1.11B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, Parkman Healthcare Partners LLC disclosed 90 equity positions with a combined reported value of $969.64M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 34.7% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were SYK ($50.86M), DXCM ($43.32M), KALV ($36.95M). By sector, the heaviest allocations are Health Care 87.3%, Consumer Staples 2.9%. Versus the prior quarter, allocation shifted toward Health Care (+14.4pp) and away from Consumer Staples (-0.5pp), Technology (-1.0pp).

Versus the prior quarter, Parkman Healthcare Partners LLC opened 26 new positions, trimmed 31 and fully exited 13, a turnover rate of 68.0% of positions. The portfolio's overlap with the prior quarter was 62% of names.

The largest new positions opened in Q1 2026 were LLY ($31.84M), NVST ($18.06M), ABBV ($16.31M).

Of the 13 positions fully exited versus the prior quarter, the largest were MASI ($26.01M), TERN ($25.08M), FOLD ($21.18M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • LLY ELI LILLY & CO · $31.84M
  • NVST ENVISTA HOLDINGS CORPORATION · $18.06M
  • ABBV ABBVIE INC · $16.31M
  • ILMN ILLUMINA INC · $13.60M
  • IDXX IDEXX LABS INC · $8.43M
  • ERAS ERASCA INC · $6.58M
  • TNGX TANGO THERAPEUTICS INC · $5.57M
  • MRNA MODERNA INC · $5.08M

Fully Exited (vs previous quarter)

  • MASI MASIMO CORP · prev qtr: $26.01M
  • TERN TERNS PHARMACEUTICALS INC · prev qtr: $25.08M
  • FOLD AMICUS THERAPEUTIC · prev qtr: $21.18M
  • MTD METTLER TOLEDO INTERNATIONAL · prev qtr: $15.32M
  • A AGILENT TECHNOLOGIES INC · prev qtr: $13.61M
  • DHR DANAHER CORP DEL · prev qtr: $13.48M
  • UNH UNITEDHEALTH GROUP INC · prev qtr: $10.52M · history
  • ACLX ARCELLX IN · prev qtr: $8.35M

Insider Transactions (Form 4)

Latest Parkman Healthcare Partners LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Parkman Healthcare Partners LLC, based in Stamford, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 77 positions worth $976.83M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: STAMFORD, CT, United States
  • SEC registration: 801-114849 (status: Approved), registered 2019-03-15
  • Regulatory AUM (Form ADV): $1.74B as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 77 positions · $976.83M reported value (Q2 2026)
  • Top 10 holdings = 33.5% of reported value
  • Largest position: MBX (MBX BIOSCIENCES INC COM) at 4.5%
  • Average position size: $12.69M

Sector Tilt

  • Health Care 92.1%
  • Consumer Staples 4.1%
  • Industrials 3.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 18 new, 25 added, 30 reduced, 31 exited
  • 4 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 87.3%
Technology 1.1%
Other 5.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 154.77K $50.86M 5.25%
5.25%
Add
2 689.82K $43.32M 4.47%
4.47%
Add
3 1.84M $36.95M 3.81%
3.81%
Add
4 156.56K $32.85M 3.39%
3.39%
Add
5 34.62K $31.84M 3.28%
3.28%
New
6 431.36K $29.39M 3.03%
3.03%
Add
7 497.04K $28.90M 2.98%
2.98%
Add
8 448.77K $28.16M 2.90%
2.90%
Reduce
9 387.31K $27.82M 2.87%
2.87%
Reduce
10 1.21M $26.08M 2.69%
2.69%
Add
11 403.96K $25.68M 2.65%
2.65%
Reduce
12 269.56K $24.37M 2.51%
2.51%
Add
13 800.04K $23.88M 2.46%
2.46%
Reduce
14 280.57K $21.58M 2.23%
2.23%
Add
15 901.51K $21.06M 2.17%
2.17%
Add
16 500.00K $20.02M 2.06%
2.06%
Add
17 711.69K $18.06M 1.86%
1.86%
New
18 1.35M $17.46M 1.80%
1.80%
Add
19 75.00K $16.31M 1.68%
1.68%
New
20 1.71M $16.26M 1.68%
1.68%
Add
21 86.70K $14.79M 1.52%
1.52%
Add
22 403.52K $13.65M 1.41%
1.41%
Add
23 110.37K $13.60M 1.40%
1.40%
New
24 167.16K $13.39M 1.38%
1.38%
Add
25 99.07K $13.05M 1.35%
1.35%
Reduce
26 259.18K $12.48M 1.29%
1.29%
Reduce
27 411.23K $11.41M 1.18%
1.18%
Add
28 232.09K $11.19M 1.15%
1.15%
Add
29 12.68K $10.97M 1.13%
1.13%
Reduce
30 336.52K $10.96M 1.13%
1.13%
Reduce
31 557.94K $10.91M 1.12%
1.12%
Reduce
32 443.06K $10.68M 1.10%
1.10%
Add
33 380.14K $10.30M 1.06%
1.06%
Reduce
34 322.83K $10.17M 1.05%
1.05%
Reduce
35 1.72M $9.98M 1.03%
1.03%
Add
36 50.12K $9.46M 0.97%
0.97%
Reduce
37 252.01K $9.23M 0.95%
0.95%
Add
38 88.08K $9.02M 0.93%
0.93%
Reduce
39 823.76K $8.96M 0.92%
0.92%
Add
40 26.92K $8.91M 0.92%
0.92%
Reduce
41 268.16K $8.88M 0.92%
0.92%
Add
42 403.49K $8.82M 0.91%
0.91%
Add
43 621.46K $8.64M 0.89%
0.89%
Add
44 15.00K $8.43M 0.87%
0.87%
New
45 26.45K $7.88M 0.81%
0.81%
Reduce
46 551.82K $7.66M 0.79%
0.79%
Add
47 786.78K $7.08M 0.73%
0.73%
Reduce
48 406.70K $6.58M 0.68%
0.68%
New
49 77.69K $6.54M 0.67%
0.67%
Reduce
50 89.88K $6.43M 0.66%
0.66%
Reduce

FAQ

What did Parkman Healthcare Partners LLC buy in 2026-Q1?

In its 2026-Q1 13F filing, Parkman Healthcare Partners LLC reported 90 equity positions worth $969.64M in aggregate; its largest disclosed positions were SYK ($50.86M), DXCM ($43.32M), KALV ($36.95M).

How large is Parkman Healthcare Partners LLC's portfolio?

Parkman Healthcare Partners LLC reported $969.64M of long equity holdings across 90 positions as of 2026-Q1. Top-10 holdings account for 34.7% of reported value.

What is Parkman Healthcare Partners LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/parkman-healthcare-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →